These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 26247926

  • 1. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N, Esparon S, Pouniotis D, Pietersz GA.
    Molecules; 2015 Aug 03; 20(8):14033-50. PubMed ID: 26247926
    [Abstract] [Full Text] [Related]

  • 2. Immunogenicity of a Tripartite Cell Penetrating Peptide Containing a MUC1 Variable Number of Tandem Repeat (VNTR) and A T Helper Epitope.
    Brooks N, Hsu J, Esparon S, Pouniotis D, Pietersz GA.
    Molecules; 2018 Sep 02; 23(9):. PubMed ID: 30200528
    [Abstract] [Full Text] [Related]

  • 3. Vaccine delivery by penetratin: mechanism of antigen presentation by dendritic cells.
    Pouniotis D, Tang CK, Apostolopoulos V, Pietersz G.
    Immunol Res; 2016 Aug 02; 64(4):887-900. PubMed ID: 27138940
    [Abstract] [Full Text] [Related]

  • 4. A membrane penetrating multiple antigen peptide (MAP) incorporating ovalbumin CD8 epitope induces potent immune responses in mice.
    Brooks NA, Pouniotis DS, Sheng KC, Apostolopoulos V, Pietersz GA.
    Biochim Biophys Acta; 2010 Dec 02; 1798(12):2286-95. PubMed ID: 20478265
    [Abstract] [Full Text] [Related]

  • 5. Incorporation of the Tat cell-penetrating peptide into nanofibers improves the respective antitumor immune response.
    Mohammadi M, Dehghani P, Mohseninia A, Roozbehani M, Hemphill A, Hesamizadeh K.
    J Cell Physiol; 2021 Feb 02; 236(2):1401-1417. PubMed ID: 32686113
    [Abstract] [Full Text] [Related]

  • 6. Whole protein and defined CD8(+) and CD4(+) peptides linked to penetratin targets both MHC class I and II antigen presentation pathways.
    Pouniotis DS, Esparon S, Apostolopoulos V, Pietersz GA.
    Immunol Cell Biol; 2011 Nov 02; 89(8):904-13. PubMed ID: 21383765
    [Abstract] [Full Text] [Related]

  • 7. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization.
    Ramakrishna L, Anand KK, Mohankumar KM, Ranga U.
    J Virol; 2004 Sep 02; 78(17):9174-89. PubMed ID: 15308713
    [Abstract] [Full Text] [Related]

  • 8. Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells.
    Tanaka Y, Dowdy SF, Linehan DC, Eberlein TJ, Goedegebuure PS.
    J Immunol; 2003 Feb 01; 170(3):1291-8. PubMed ID: 12538688
    [Abstract] [Full Text] [Related]

  • 9. The Tat-conjugated N-terminal region of mucin antigen 1 (MUC1) induces protective immunity against MUC1-expressing tumours.
    Yang H, Cho NH, Seong SY.
    Clin Exp Immunol; 2009 Nov 01; 158(2):174-85. PubMed ID: 19737144
    [Abstract] [Full Text] [Related]

  • 10. Penetratin tandemly linked to a CTL peptide induces anti-tumour T-cell responses via a cross-presentation pathway.
    Pouniotis DS, Apostolopoulos V, Pietersz GA.
    Immunology; 2006 Mar 01; 117(3):329-39. PubMed ID: 16476052
    [Abstract] [Full Text] [Related]

  • 11. Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model.
    Kadkhodayan S, Jafarzade BS, Sadat SM, Motevalli F, Agi E, Bolhassani A.
    Immunol Lett; 2017 Aug 01; 188():38-45. PubMed ID: 28602843
    [Abstract] [Full Text] [Related]

  • 12. The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: implications for the design of new vaccination strategies against AIDS.
    Gavioli R, Cellini S, Castaldello A, Voltan R, Gallerani E, Gagliardoni F, Fortini C, Cofano EB, Triulzi C, Cafaro A, Srivastava I, Barnett S, Caputo A, Ensoli B.
    Vaccine; 2008 Jan 30; 26(5):727-37. PubMed ID: 18096278
    [Abstract] [Full Text] [Related]

  • 13. Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses.
    Apostolopoulos V, Pouniotis DS, van Maanen PJ, Andriessen RW, Lodding J, Xing PX, McKenzie IF, Loveland BE, Pietersz GA.
    Vaccine; 2006 Apr 12; 24(16):3191-202. PubMed ID: 16480791
    [Abstract] [Full Text] [Related]

  • 14. The neuroprotective efficacy of cell-penetrating peptides TAT, penetratin, Arg-9, and Pep-1 in glutamic acid, kainic acid, and in vitro ischemia injury models using primary cortical neuronal cultures.
    Meloni BP, Craig AJ, Milech N, Hopkins RM, Watt PM, Knuckey NW.
    Cell Mol Neurobiol; 2014 Mar 12; 34(2):173-81. PubMed ID: 24213248
    [Abstract] [Full Text] [Related]

  • 15. Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.
    Buhl T, Braun A, Forkel S, Möbius W, van Werven L, Jahn O, Rezaei-Ghaleh N, Zweckstetter M, Mempel M, Schön MP, Haenssle HA.
    Exp Dermatol; 2014 Jan 12; 23(1):20-6. PubMed ID: 24372650
    [Abstract] [Full Text] [Related]

  • 16. Augmented induction of CD8+ cytotoxic T-cell response and antitumour resistance by T helper type 1-inducing peptide.
    Kikuchi T, Uehara S, Ariga H, Tokunaga T, Kariyone A, Tamura T, Takatsu K.
    Immunology; 2006 Jan 12; 117(1):47-58. PubMed ID: 16423040
    [Abstract] [Full Text] [Related]

  • 17. Efficient induction of human T-cell leukemia virus-1-specific CTL by chimeric particle without adjuvant as a prophylactic for adult T-cell leukemia.
    Kozako T, Fukada K, Hirata S, White Y, Harao M, Nishimura Y, Kino Y, Soeda S, Shimeno H, Lemonnier F, Sonoda S, Arima N.
    Mol Immunol; 2009 Dec 12; 47(2-3):606-13. PubMed ID: 19889459
    [Abstract] [Full Text] [Related]

  • 18. Enhancing the Antimicrobial Properties of Peptides through Cell-Penetrating Peptide Conjugation: A Comprehensive Assessment.
    Kravchenko SV, Domnin PA, Grishin SY, Vershinin NA, Gurina EV, Zakharova AA, Azev VN, Mustaeva LG, Gorbunova EY, Kobyakova MI, Surin AK, Fadeev RS, Ostroumova OS, Ermolaeva SA, Galzitskaya OV.
    Int J Mol Sci; 2023 Nov 24; 24(23):. PubMed ID: 38069046
    [Abstract] [Full Text] [Related]

  • 19. [Identification of T cell epitopes from ovarian cancer associated anti-idiotype antibody].
    Li W, Cui H, Chang XH, Cheng HY, Cheng YX, Feng J, Fu TY.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Oct 24; 43(10):764-9. PubMed ID: 19087545
    [Abstract] [Full Text] [Related]

  • 20. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
    Ohtake J, Ohkuri T, Togashi Y, Kitamura H, Okuno K, Nishimura T.
    Immunol Lett; 2014 Sep 24; 161(1):20-30. PubMed ID: 24794408
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.